Novo Nordisk Bangladesh have announced the start of local production of modern insulin cartridges (Penfill) in Bangladesh ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Two years ago, California made a bold ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on Grocery Dive. To receive daily news and insights, subscribe to our free daily Grocery Dive ...

Eskayef has entered a technology transfer arrangement with Novo Nordisk, which supplies roughly 40 percent of Bangladesh's ...

Sanofi SAN-0.12%decrease; red down pointing triangle plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest single investment in the ...

Utah-based Civica will begin selling a type of long-acting insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility. Civica announced Thursday it has ...

Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal reports. The company said the investment will enhance the ...

BANGALORE, March 9 (Reuters) - MannKind Corp said it agreed to buy Pfizer Inc's insulin plant in Germany and a manufacturing license for $33 million, giving it the right to make its own insulin and a ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the potential ...